ALK-Abelló A/S

    Jurisdiction
    Denmark
    LEI
    529900SGCREUZCZ7P020
    ISIN
    DK0061802139 (ALK-B.CO)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €19.52 47.3% overvalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Read full profile

    Fundamentals

    Net revenue
    €785.19M
    Gross margin
    65.0%
    EBIT
    €181.53M
    EBIT margin
    23.1%
    Net income
    €133.84M
    Net margin
    17.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €934.44M +19.0% €179.51M +34.1%
    €1.05B +12.5% €206.15M +14.8%
    €1.19B +13.1% €236.30M +14.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    DKK 5.00
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: August 21, 2025 (Q2 2025)

    Add to watchlist

    Notifications